Banner image
OMP

An industry leader in the fast-growing digitized supply chain planning (SCP) market.

Included in the AvH investment portfolio since 2020.

20.01 %

Beneficial interest AvH
Omp-Bis

Key financial highlights


248 m

Turnover (2025)

43 m

Net result (2025)

Press releases - Growth capital

View All
Growth Capital

Biotalys Obtains Subscription Commitments for EUR 12.05 Million through a Private Placement of New Shares with Current Investors

Growth Capital

Confo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate, CFTX-1554